The Glucagon-Like Peptide-1 Analogue Liraglutide Reduces Seizures Susceptibility, Cognition Dysfunction and Neuronal Apoptosis in a Mouse Model of Dravet Syndrome. This evidence concerns the gene GCG and encephalopathy, progressive, early-onset, with brain edema and/or leukoencephalopathy.